[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581417":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":18,"responsibleParty":116,"collaborators":7,"id":118,"slug":119,"hasResults":120,"nctId":121,"briefTitle":122,"officialTitle":123,"acronym":7,"eligibilityCriteria":124,"healthyVolunteers":120,"sex":125,"minAge":7,"maxAge":7,"enrollmentInfo":126,"targetDuration":129,"studyType":130,"phases":7,"briefSummary":131,"conditions":132,"keywords":7,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":134,"lastUpdatePostDateStruct":135,"startDateStruct":138,"completionDateStruct":140,"leadSponsor":142,"locationsCount":143},{"fullName":5,"class":6},"Ipsen","INDUSTRY",null,[9],{"name":10,"affiliation":5,"role":11},"Ipsen Medical, Director","STUDY_DIRECTOR",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Ipsen Recruitment Enquiries","CONTACT","See email","clinical.trials@ipsen.com",[19,33,42,52,62,71,77,87,97,106],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":7},"Children's Hospital Los Angeles","RECRUITING","Los Angeles","California","90027","United States","US",{"type":28,"coordinates":29},"Point",[30,31],-118.24368,34.05223,{"lat":31,"lon":30},{"facility":34,"status":21,"city":35,"state":23,"zip":36,"country":25,"countryCode":26,"cosmosGeoPoint":37,"geoPoint":41,"contacts":7},"UCSF Benioff Children's Hospital","San Francisco","94158",{"type":28,"coordinates":38},[39,40],-122.41942,37.77493,{"lat":40,"lon":39},{"facility":43,"status":21,"city":44,"state":45,"zip":46,"country":25,"countryCode":26,"cosmosGeoPoint":47,"geoPoint":51,"contacts":7},"The Children's Mercy Hospital","Kansas City","Missouri","64108",{"type":28,"coordinates":48},[49,50],-94.57857,39.09973,{"lat":50,"lon":49},{"facility":53,"status":54,"city":55,"state":45,"zip":56,"country":25,"countryCode":26,"cosmosGeoPoint":57,"geoPoint":61,"contacts":7},"SSM Health Cardinal Glennon Children's Hospital","NOT_YET_RECRUITING","St Louis","63104",{"type":28,"coordinates":58},[59,60],-90.19789,38.62727,{"lat":60,"lon":59},{"facility":63,"status":21,"city":64,"state":64,"zip":65,"country":25,"countryCode":26,"cosmosGeoPoint":66,"geoPoint":70,"contacts":7},"NYU Langone - NYU Grossman School of Medicine","New York","10016",{"type":28,"coordinates":67},[68,69],-74.00597,40.71427,{"lat":69,"lon":68},{"facility":72,"status":21,"city":64,"state":64,"zip":73,"country":25,"countryCode":26,"cosmosGeoPoint":74,"geoPoint":76,"contacts":7},"Columbia University Medical Center - Morgan Stanley Children's Hospital of NewYork - Presbyterian (MS-CHONY)","10032",{"type":28,"coordinates":75},[68,69],{"lat":69,"lon":68},{"facility":78,"status":21,"city":79,"state":80,"zip":81,"country":25,"countryCode":26,"cosmosGeoPoint":82,"geoPoint":86,"contacts":7},"Le Bonheur Children's Hospital","Memphis","Tennessee","38105",{"type":28,"coordinates":83},[84,85],-90.04898,35.14953,{"lat":85,"lon":84},{"facility":88,"status":21,"city":89,"state":90,"zip":91,"country":25,"countryCode":26,"cosmosGeoPoint":92,"geoPoint":96,"contacts":7},"Children's Medical Center Of Dallas","Dallas","Texas","75246",{"type":28,"coordinates":93},[94,95],-96.80667,32.78306,{"lat":95,"lon":94},{"facility":98,"status":21,"city":99,"state":90,"zip":100,"country":25,"countryCode":26,"cosmosGeoPoint":101,"geoPoint":105,"contacts":7},"Proactive El Paso,LLC","El Paso","79902",{"type":28,"coordinates":102},[103,104],-106.48693,31.75872,{"lat":104,"lon":103},{"facility":107,"status":54,"city":108,"state":109,"zip":110,"country":25,"countryCode":26,"cosmosGeoPoint":111,"geoPoint":115,"contacts":7},"Primary Children's Hospital (PCH) - Intermountain Healthcare\u002FUniversity of Utah","Salt Lake City","Utah","84113",{"type":28,"coordinates":112},[113,114],-111.89105,40.76078,{"lat":114,"lon":113},{"type":117,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100581417","a-study-observing-the-long-term-effectiveness-and-safety-of-odevixibat-bylvay-in-patients-with-alagille-syndrome-algs-who-are-receiving-ongoing-treatment-100581417",false,"NCT06850038","A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment","Prospective Registry-Based Study Evaluating the Effectiveness and Safety of Odevixibat in Participants With Alagille Syndrome (ALGS)","Inclusion Criteria:\n\n* Diagnosed with ALGS.\n* On (or starting) active odevixibat treatment.\n* Signed informed consent and assent, as appropriate. Consent\u002Fassent from the participant or legal representative should be obtained, as appropriate, before any study data collection is conducted. Participants who turn 18 years of age (or legal age per country) while participating in the study will be required to provide consent for themselves.\n\nExclusion Criteria:\n\n* Currently participating in a clinical trial with odevixibat.\n* Currently participating in any interventional clinical trial for ALGS.\n* Have any contraindication to odevixibat as per the locally approved label.\n* Had liver transplant before enrolment","ALL",{"count":127,"type":128},30,"ESTIMATED","2 Years","OBSERVATIONAL","This study will collect information from patients with Alagille syndrome (ALGS) as they use odevixibat (Bylvay) in their daily lives.\n\nOdevixibat is a medicine that helps patients with ALGS, a rare disease that harms their liver and causes itching.\n\nThe main aim of this study is to observe the long-term, everyday effectiveness and safety of the drug odevixibat in patients with ALGS who are receiving ongoing treatment.",[133],"Alagille Syndrome","2026-07-01",{"date":136,"type":137},"2026-07-02","ACTUAL",{"date":139,"type":137},"2025-04-22",{"date":141,"type":128},"2029-11",{"name":5,"class":6},10]